1-10 of 10
D. Siegel
Close
Sort by
Journal Articles

A Phase 1b, Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) with Vincristine and Dexamethasone in Adult Subjects with Relapsed or Refractory Acute Lymphoid Leukemia (ALL)

Mark D. Minden, MD PhD, Wendy Stock, MD, Howland Crosswell, MD, Robert D Siegel, MD, Patrick Chun, MD, Steve Abella, MD, Jing He, Clarence Eng, MPH, Dan Douer, MD
Journal: Blood
Blood (2015) 126 (23): 4866.
https://doi.org/10.1182/blood.V126.23.4866.4866
Published: 2015
Journal Articles

A Phase IB, Multicenter, Open-Label, Dose-Escalation Study of Oral Panobinostat (LBH589) and I.V. Bortezomib in Patients with Relapsed Multiple Myeloma

Davi d Siegel, Orhan Sezer, Jesus F. San Miguel, Maria-Victoria Mateos, Ian Prosser, Michele Cavo, Muhammad Jalaluddin, Katharine Hazell, Priscille M. Bourquelot, Kenneth C. Anderson, MD
Journal: Blood
Blood (2008) 112 (11): 2781.
https://doi.org/10.1182/blood.V112.11.2781.2781
Published: 2008
Journal Articles

Clinical Efficacy of Oral Vorinostat Combined with Lenalidomide and Dexamethasone in a Patient with Refractory End-Stage Multiple Myeloma – a Patient Case Study

Davi D Siegel, Karly Olivo
Journal: Blood
Blood (2008) 112 (11): 5218.
https://doi.org/10.1182/blood.V112.11.5218.5218
Published: 2008
Journal Articles

Safety and Efficacy of Bortezomib in Multiple Myeloma Patients with Renal Failure Requiring Dialysis.

Asher Alban Chanan-Khan, P. Richardson, S. Lonial, D. Siegel, S. Jagannath, J. Mehta, J. Doran, S. Singhal
Journal: Blood
Blood (2005) 106 (11): 2550.
https://doi.org/10.1182/blood.V106.11.2550.2550
Published: 2005
Journal Articles

Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

B. Barlogie, S. Jagannath, K.R. Desikan, S. Mattox, D. Vesole, D. Siegel, G. Tricot, N. Munshi, A. Fassas, S. Singhal, J. Mehta, E. Anaissie, D. Dhodapkar, S. Naucke, J. Cromer, J. Sawyer, J. Epstein, D. Spoon, D. Ayers, B. Cheson, J. Crowley
Journal: Blood
Blood (1999) 93 (1): 55–65.
https://doi.org/10.1182/blood.V93.1.55
Published: 1999
Journal Articles

Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple Myeloma

G. Tricot, Y. Gazitt, T. Leemhuis, S. Jagannath, K.R. Desikan, D. Siegel, A. Fassas, S. Tindle, J. Nelson, C. Juttner, A. Tsukamoto, J. Hallagan, K. Atkinson, C. Reading, R. Hoffman, B. Barlogie
Journal: Blood
Blood (1998) 91 (12): 4489–4495.
https://doi.org/10.1182/blood.V91.12.4489
Published: 1998
Journal Articles

Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell Transplantation

C.S. Zent, C.S. Wilson, G. Tricot, S. Jagannath, D. Siegel, K.R. Desikan, N. Munshi, D. Bracy, B. Barlogie, A.W. Butch
Journal: Blood
Blood (1998) 91 (9): 3518–3523.
https://doi.org/10.1182/blood.V91.9.3518
Published: 1998
Journal Articles

Autotransplants in multiple myeloma: what have we learned?

DH Vesole, G Tricot, S Jagannath, KR Desikan, D Siegel, D Bracy, L Miller, B Cheson, J Crowley, B Barlogie
Journal: Blood
Blood (1996) 88 (3): 838–847.
https://doi.org/10.1182/blood.V88.3.838.838
Published: 1996
Journal Articles

Proteinaceous (angiocentric sclerosing) lymphadenopathy: a polyclonal systemic, nonamyloid deposition disorder

J Michaeli, R Niesvizky, D Siegel, M Ladanyi, PH Lieberman, DA Filippa
Journal: Blood
Blood (1995) 86 (3): 1159–1162.
https://doi.org/10.1182/blood.V86.3.1159.1159
Published: 1995
Journal Articles

2-Chlorodeoxyadenosine for multiple myeloma [letter; comment]

R Niesvizky, D Siegel, J Michaeli
Journal: Blood
Blood (1993) 81 (3): 868–869.
https://doi.org/10.1182/blood.V81.3.868.868
Published: 1993